Izquierdo G, Hauw JJ, Lyon-Caen O, Marteau R, Escourolle R, Buge A, et al. Clinical analysis of 70 neuropathologic cases of multiple sclerosis. Rev Neurol (Paris). 1985;141(8–9):546–52.
Kilsdonk ID, Lopez-Soriano A, Kuijer JP, de Graaf WL, Castelijns JA, Polman CH, et al. Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics. J Neurol. 2014;261(7):1356–64.
Van Der Valk P, De Groot CJA. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol. 2000;26(1):2–10.
Van Waesberghe JHTM, Kamphorst W, De Groot CJA, Van Walderveen MAA, Castelijns JA, Ravid R, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol. 1999;46(5):747–54.
Brightman MW, Reese TS. Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol. 1969;40(3):648–77.
Article CAS PubMed PubMed Central Google Scholar
Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003;161(3):653–60.
Article CAS PubMed PubMed Central Google Scholar
Li W, Chen Z, Chin I, Chen Z, Dai H. The role of VE-cadherin in blood-brain barrier integrity under central nervous system pathological conditions. Curr Neuropharmacol. 2018;16(9):1375–84.
Article CAS PubMed PubMed Central Google Scholar
Alvarez JI, Saint-Laurent O, Godschalk A, Terouz S, Briels C, Larouche S, et al. Focal disturbances in the blood–brain barrier are associated with formation of neuroinflammatory lesions. Neurobiol Dis. 2015;74:14–24.
Article CAS PubMed Google Scholar
Plumb J, McQuaid S, Mirakhur M, Kirk J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol. 2002;12(2):154–69.
Kooij G, Mizee MR, van Horssen J, Reijerkerk A, Witte ME, Drexhage JA, et al. Adenosine triphosphate-binding cassette transporters mediate chemokine (C–C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis. Brain. 2011;134(Pt 2):555–70.
Engelhardt B, Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood–brain barriers. Trends Immunol. 2012;33(12):579–89.
Article CAS PubMed Google Scholar
Vos CMP, Geurts JJG, Montagne L, van Haastert ES, Bö L, van der Valk P, et al. Blood–brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol Dis. 2005;20(3):953–60.
Article CAS PubMed Google Scholar
Stone LA, Smith ME, Albert PS, Bash CN, Maloni H, Frank JA, McFarland HF. Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology. 1995;45(6):1122–6.
Article CAS PubMed Google Scholar
Davalos D, Kyu Ryu J, Merlini M, Baeten KM, Le Moan N, Petersen MA, et al. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun. 2012;3(1):1227.
Yates RL, Esiri MM, Palace J, Jacobs B, Perera R, DeLuca GC. Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex. Ann Neurol. 2017;82(2):259–70.
Article CAS PubMed Google Scholar
Cramer SP, Simonsen H, Frederiksen JL, Rostrup E, Larsson HBW. Abnormal blood–brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI. NeuroImage Clin. 2014;4:182–9.
Article CAS PubMed Google Scholar
Berghoff SA, Düking T, Spieth L, Winchenbach J, Stumpf SK, Gerndt N, et al. Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model. Acta Neuropathol Commun. 2017;5(1):94.
Article PubMed PubMed Central Google Scholar
Abbott NJ. Role of intracellular calcium in regulation of brain endothelial permeability. Cambridge: University Press; 1998.
De Bock M, Wang N, Decrock E, Bol M, Gadicherla AK, Culot M, et al. Endothelial calcium dynamics, connexin channels and blood–brain barrier function. Prog Neurobiol. 2013;108:1–20.
Kubicka-Baczyk K, Labuz-Roszak B, Pierzchala K, Adamczyk-Sowa M, Machowska-Majchrzak A. Calcium-phosphate metabolism in patients with multiple sclerosis. J Endocrinol Invest. 2015;38(6):635–42.
Article CAS PubMed PubMed Central Google Scholar
Wilhelm I, Farkas AE, Nagyőszi P, Váró G, Bálint Z, Végh GA, et al. Regulation of cerebral endothelial cell morphology by extracellular calcium. Phys Med Biol. 2007;52(20):6261.
Article CAS PubMed Google Scholar
De Bock M, Culot M, Wang N, da Costa A, Decrock E, Bol M, et al. Low extracellular Ca2+ conditions induce an increase in brain endothelial permeability that involves intercellular Ca2+ waves. Brain Res. 2012;1487:78–87.
Abbott NJ. Inflammatory Mediators and Modulation of Blood-Brain Barrier Permeability. Cell Mol Neurobiol. 2000;20(2):131–47.
Article CAS PubMed Google Scholar
de Vries HE, Blom-Roosemalen MCM, Mv O, de Boer AG, van Berkel TJC, Breimer DD, Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol. 1996;64(1):37–43.
Rakkar K, Bayraktutan U. Increases in intracellular calcium perturb blood–brain barrier via protein kinase C-alpha and apoptosis. Biochim Biophys Acta Mol Basis Dis. 1862;1:56–71.
Brown RC, O’Neil RG. Mechanosensitive calcium fluxes in the neurovascular unit: TRP channel regulation of the blood-brain barrier. In: Kamkim A, Kiseleva I, editors. Mechanosensitivity of the nervous system: forewords by nektarios tavernarakis and pontus persson. Dordrecht: Springer; 2009. p. 321–43.
Campbell WB, Fleming I. Epoxyeicosatrienoic acids and endothelium-dependent responses. Pflügers Arch Eur J Physiol. 2010;459(6):881–95.
Schampel A, Kuerten S. Danger: high voltage-the role of voltage-gated calcium channels in central nervous system pathology. Cells. 2017;6(4):43.
Article PubMed PubMed Central Google Scholar
Brown RC, Wu L, Hicks K, O’Neil RG. Regulation of blood-brain barrier permeability by transient receptor potential type C and type V calcium-permeable channels. Microcirculation. 2008;15(4):359–71.
Article CAS PubMed PubMed Central Google Scholar
Bagnell AM, Sumner CJ, McCray BA. TRPV4: a trigger of pathological RhoA activation in neurological disease. BioEssays. 2022;44(6): e2100288.
Article PubMed PubMed Central Google Scholar
Ramirez GA, Coletto LA, Sciorati C, Bozzolo EP, Manunta P, Rovere-Querini P, Manfredi AA. Ion channels and transporters in inflammation: special focus on TRP channels and TRPC6. Cells. 2018;7(7):70.
Article PubMed PubMed Central Google Scholar
Çiğ B, Derouiche S, Jiang LH. Editorial: emerging roles of TRP channels in brain pathology. Front Cell Dev Biol. 2021;9: 705196.
Article PubMed PubMed Central Google Scholar
Tiruppathi C, Ahmmed GU, Vogel SM, Malik AB. Ca 2+ signaling, TRP channels, and endothelial permeability. Microcirculation. 2006;13(8):693–708.
Article CAS PubMed Google Scholar
Zheng X, Zinkevich NS, Gebremedhin D, Gauthier KM, Nishijima Y, Fang J, et al. Arachidonic acid-induced dilation in human coronary arterioles: convergence of signaling mechanisms on endothelial TRPV4-mediated Ca2+ entry. J Am Heart Assoc. 2013;2(3): e000080.
Article PubMed PubMed Central Google Scholar
Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature. 2003;424(6947):434–8.
Article CAS PubMed Google Scholar
Darby WG, Potocnik S, Ramachandran R, Hollenberg MD, Woodman OL, McIntyre P. Shear stress sensitizes TRPV4 in endothelium-dependent vasodilatation. Pharmacol Res. 2018;133:152–9.
Article CAS PubMed Google Scholar
Michalick L, Kuebler WM. TRPV4: a missing link between mechanosensation and immunity. Front Immunol. 2020;11:413.
留言 (0)